|||
最近来自成都中医药大学的一篇假说,提出氢气可能具有对抗酒精毒性损伤的作用, 确实目前仍没有这方面的研究, 这应该是一个值得研究的问题. 台湾作氢气水的公司开发一种产品, 为不醉. 就是氢气水, 据说喝了可以提高酒量, 但实话说, 我自己喝氢气水并没有觉得酒量增加多少. 喝过酒, 眼睛不舒服, 用氢气水洗眼睛感觉不错. 但这些都属于没有确认的, 不好作为证据.
Abstract
Alcohol consumption has been identified as a major risk factor for chronic disease and injury, imposing a considerable burden on sufferers, their families and society. Growing evidence suggests that increased oxidative stress caused by excessive use of alcohol is associated with many diseases. Nevertheless, there is no antioxidant that can protect all organs and tissues in the body from alcohol-mediated oxidative damage. Notably, recent basic and clinical research has confirmed that molecular hydrogen can markedly decrease oxidative stress by selectively scavenging noxious reactive oxygen species (ROS), and protect cells and tissues against oxidative insults. Based on these data, it is hypothesized that hydrogen gas would be a favorable antioxidant additive for alcoholic beverages, namely hydrogen-rich alcohol. Molecular hydrogen may also be administered by alternative methods, involving direct inhalation, oral intake of hydrogen dissolved in water, and injection with hydrogen-saturated fluid, to ameliorate the oxidative damage derived from ethanol exposure, especially alcohol-induced liver disease.
--------------------------------------------------------------------------------
Introduction
Across cultural boundaries, alcohol has been consumed as a part of human life for thousands of years. Although moderate alcohol consumption appears to be associated with favorable changes in several cardiovascular biomarkers of coronary heart disease and a reduced risk of multiple cardiovascular outcomes (1, 2) the overall effect of alcohol use on health is overwhelmingly detrimental, even in regions in which the net cardiovascular outcome is beneficial (3). Indeed, alcohol consumption has been identified as a major risk factor for chronic disease and injury (3), imposing a considerable burden on sufferers, their families and society. In 2004, 3.8% of all global deaths and 4.6% of the global burden of disease and injury were attributable to alcohol (3). Reactive oxygen species (ROS), a class of oxygen-containing free radicals, are generated in small amounts as a natural byproduct of the body’s metabolic reactions and can react with and damage complex molecules in the cells, such as lipids, proteins, and DNA (4). It is well established that both acute and chronic alcohol exposure can increase ROS production, lower cellular antioxidant levels, and enhance oxidative stress in many tissues, including liver, heart, brain, and peripheral nerves. Alcohol-induced oxidative stress plays a dominant role in the development of alcoholic liver disease, which is one of major causes of preventable illness and death worldwide (4, 5) and is also implicated in many other disorders that plague human beings, including fetal alcohol syndrome (6), alcohol use disorder (7), alcoholic pancreatitis (8) and hepatocellular carcinoma (9).
Interestingly, beer, wine, and liquor all contain natural compounds with antioxidative properties. Resveratrol, a polyphenol that is abundant in wine, has been under intense study in a multitude of health conditions. This includes protection against mortality and liver lesions caused by alcohol in mice (10) attenuation of intestinal ischemia and reperfusion injury in rats (11) and significant improvement in cognitive deficits and brain damage in rats postnatally exposed to alcohol by blocking activation of nuclear factor kappa beta (NFkß) pathway and apoptotic signaling (12). Despite promising results, a convenient, effective, and safe approach that protects all organs from alcohol-mediated oxidative impairment is yet to be developed.
Recent Advances in Hydrogen Research as an Antioxidant Medical Gas
Hydrogen is the lightest and most abundant chemical element, constituting nearly 75% of the universe’s elemental mass. As a highly combustible diatomic gas with the molecular formula H2, hydrogen is seldom regarded as a therapeutic gas. Interestingly, in 1975, a study reported that hyperbaric hydrogen therapy induced marked regression of tumors in hairless albino mice with squamous cell carcinoma (13). This outcome may be partially due to hydroxyl radical (•OH) scavenging by hydrogen. A quarter of a century later, Gharib and colleagues found that animals infected percutaneously with Schistosoma mansoni and maintained in a hydrogen-supplemented hyperbaric chamber were significantly protected from schistosomiasis-induced liver injury, namely reduction of liver fibrosis, with increased activity of the hydrogen peroxide (H2O2) scavenging enzymes catalase and glutathione peroxidase, decreased lipid peroxide levels, and reduced circulating tumor necrosis factor-α (TNF-α) levels (14). Consistent with previous reports showing the antioxidant effect of hydrogen, it was found that H2 selectively reduced cellular •OH and protected cultured cells, selectively reacted with and reduced cytotoxic oxygen radicals of •OH and peroxynitrite (ONOO–) in cell-free systems, and significantly protected neurons against oxidative stress-induced cell death during in vitro ischemia and reperfusion (15). In a focal ischemia rat model, inhalation of H2 not only resulted in a clear H2-dependent decrease in infarct volume, with 2–4% of H2 providing the most substantial effect, but also suppressed the progression of damage (15). So far, there is growing basic and clinical evidence highlighting the potency of hydrogen as a promising antioxidant in preventive and therapeutic applications (16,17). Several rodent studies indicate that oral intake of hydrogen water has the potential to prevent superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice (18), retard the development and progression of Parkinson’s disease in a rat model (19), prevent atherosclerosis in apolipoprotein E knockout mice (20), alleviate cisplatin-induced nephrotoxicity without compromising anti-tumor activity (21), and slow the progression of chronic allograft nephropathy in a model of kidney transplantation (22). Meanwhile, other methods of hydrogen intake, for example, injection of hydrogen saline, direct absorption of hydrogen, and increasing the production of intestinal hydrogen, have also been successfully established (17).
On the basis of encouraging data from previous studies, several groups have started clinical assessments of hydrogen-rich water. Patients with either type 2 diabetes mellitus or impaired glucose tolerance were treated with hydrogen dissolved in water (0.9 L/day) for 8 weeks. The results showed that intake of hydrogen-rich water had beneficial effects on lipid and glucose metabolism by providing protection against oxidative stress (23). In an open-label study, 20 subjects with potential metabolic syndrome, which is associated with elevated oxidative stress, were asked to regularly drink hydrogen-rich water (1.5-2 L/day) generated via a magnesium stick (24). The consumption of hydrogen-rich water for 8 weeks led to a 39% increase in antioxidant enzyme superoxide dismutase and a 43% decrease in thiobarbituric acid reactive substances in urine, accompanied by an 8% increase in high density lipo-protein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4. Nakayama et al. (25) conducted a 6-month clinical study of hemodialysis using solutions with dissolved H2. A significant decrease in systolic blood pressure (SBP) before and after dialysis was observed during the study, with no adverse effects, and a significant number of patients achieved SBP
The Hypothesis
Alcohol is metabolized primarily in liver, and many processes and factors are involved in causing a state of oxidative stress in diverse tissues, with the production of different types of ROS, such as superoxide anion radical (•O2–), nitric oxide (NO), H2O2, •OH, and ONOO–4. Accumulated evidence has confirmed that H2 can markedly decrease oxidative stress by selectively scavenging the noxious ROS •OH and ONOO–, and protect cells and tissues against oxidative damage in a variety of disease models (16,17). These findings further support the presumption that hydrogen gas would be a favorable additive for alcoholic beverages, namely hydrogen-rich alcohol, to prevent healthy people, who either usually abstain from drinking alcohol or have a light to moderate alcohol consumption, from possible injury of liver or other organs and tissues, especially during occasional heavy drinking. In addition, hydrogen-rich alcohol may decrease the persistent oxidative insults in alcohol users resulting from chronic alcohol exposure. Molecular hydrogen may also be applied by different delivery methods, involving direct inhalation, oral intake of hydrogen dissolved in water, and injection with hydrogen-saturated fluid, as a separate treatment to ameliorate the oxidative damage in individuals with alcohol-induced disorders. In brief, this hypothesis underlines the potential of H2-based prophylactic or therapeutic approaches to deal with the injury in various organ systems of the body in which alcohol-related oxidative stress plays an important role. It must be strongly emphasized that the strategy provided here is not to encourage the consumption of alcohol, but to offer a novel cost-effective intervention for oxidative impairment brought about by excessive alcohol ingestion, especially alcohol-induced liver disease.
Discussion
Oxidative stress represents an imbalance between the activity of antioxidant defense systems and the production of ROS, and is now recognized as a major causative factor in the pathogenesis of alcoholic injury. Although a host of antioxidants have been found to possess the ability to attenuate alcohol-induced injury, there is currently no antioxidant that protects all organs, tissues, and cells during all modes of exposure (5). Increasing evidence has revealed that H2 has a number of advantages as a potential antioxidant adjuvant for alcoholic beverages or a potentially novel drug with a significant clinical benefit to protect cells from oxidative insults engendered by alcohol exposure. Firstly, molecular hydrogen can increase antioxidant enzyme activity and levels (14,24), selectively attenuate •OH as well as ONOO–, the strongest cytotoxic ROS, and does not interfere with the metabolism involved in oxidation-reduction reactions or the levels of essential ROS, such as •O2–, H2O2, and NO, which are implicated in signal transduction (15). This means that H2 treatment is potentially mild enough not to produce serious side effects (15). However, a systematic review and meta-analysis found that some conventional antioxidant supplements with strong reductive reactivity, including beta carotene, vitamin A, and vitamin E, increased all-cause mortality, possibly by disturbing essential defensive mechanisms (28). Secondly, H2 is highly diffusible and can readily permeate biological membranes and diffuse into the cytosol, mitochondria, and nucleus, which contributes to effectively reducing cytotoxic radicals (15), while most known antioxidants fail to successfully target organelles (29). In fact, improvements in mitochondrial dysfunction in MM have been observed with administration of hydrogen-rich water (29). Finally, hydrogen is a colorless, odorless, and tasteless gas, which ensures an inappreciable change in the alcoholic beverage after being mixed with H2, including in color, bouquet, and taste. In addition, the safety of hydrogen for humans is demonstrated by its application in Hydreliox, a breathing gas mixture of 49% hydrogen, 50% helium, and 1% oxygen, used for very deep technical diving30. These favorable properties, together with recent progress in hydrogen medicine showing the therapeutic opportunities of hydrogen in a variety of disease models, suggest that hydrogen has the potential to not only serve as a safe and available additive for alcoholic beverages, but also act as a promising therapeutic agent for alcohol-induced disorders including alcoholic liver disease. Nevertheless, stringent animal and clinical investigations are required for roundly assessing the biological safety and effectiveness of this hypothesis.H
--------------------------------------------------------------------------------
About the Author
Dr. Yu Lai is a lecturer of Department of Microbiology and Immunology at Chengdu University of Traditional Chinese Medicine. He teaches courses in Medical Microbiology and Immunology to students in Nursing and clinical medicine, and is also interested in raising new concept for stem cell-based anti-HIV gene therapy or other potential medical hypotheses.
References
1.Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636 http://dx.doi.org/10.1136/bmj.d636 PMid:21343206 PMCid:3043110
2.Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342:d671. http://dx.doi.org/10.1136/bmj.d671 PMid:21343207 PMCid:3043109
3.Rehm J, Mathers C, Popova S, Thavorncharoen-sap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223-33. http://dx.doi.org/10.1016/S0140-6736(09)60746-7
4.Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis. 2009;29:141-54. http://dx.doi.org/10.1055/s-0029-1214370 PMid:19387914
5.McDonough KH. Antioxidant nutrients and alcohol. Toxicology. 2003;189:89-97.
http://dx.doi.org/10.1016/S0300-483X(03)00155-0
6.Drever N, Yin H, Kechichian T, Costantine M, Longo M, Saade GR, et al. The expression of antioxidant enzymes in a mouse model of fetal alcohol syndrome. Am J Obstet Gynecol. 2012;206:358 e19-22.
7.Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010;68:261-75. http://dx.doi.org/10.1016/j.neures.2010.08.007 PMid:20804792
8.Szuster-Ciesielska A, Daniluk J, Kandefer-Szerszen M. Oxidative stress in blood of patients with alcohol-related pancreatitis. Pancreas. 2001;22:261-6. http://dx.doi.org/10.1097/00006676-200104000-00006 PMid:11291927
9.Petersen DR. Alcohol, iron-associated oxidative stress, and cancer. Alcohol. 2005;35:243-9. http://dx.doi.org/10.1016/j.alcohol.2005.03.013 PMid:16054986
10.Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, Bidaurrazaga J, de Luco MF, Gutierrez-Stampa M, et al. Effect of resveratrol on alcohol-induced mortality and liver lesions in mice. BMC Gastroenterol. 2006;6:35.
http://dx.doi.org/10.1186/1471-230X-6-35 PMid:17105669 PMCid:1657014
11.Ozkan OV, Yuzbasioglu MF, Ciralik H, Kurutas EB, Yonden Z, Aydin M, et al. Resveratrol, a natural antioxidant, attenuates intestinal ischemia/reperfusion injury in rats. Tohoku J Exp Med. 2009;218:251-8. http://dx.doi.org/10.1620/tjem.218.251 PMid:19561396
12.Tiwari V, Chopra K. Resveratrol prevents alcohol-induced cognitive deficits and brain damage by blocking inflammatory signaling and cell death cascade in neonatal rat brain. J Neurochem. 2011;117:678-90. PMid:21375533
13.Dole M, Wilson FR, Fife WP. Hyperbaric hydrogen therapy: a possible treatment for cancer. Science. 1975;190:152-4.
http://dx.doi.org/10.1126/science.1166304 PMid:1166304
14.Gharib B, Hanna S, Abdallahi OM, Lepidi H, Gardette B, De Reggi M. Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. C R Acad Sci III. 2001;324:719-24. http://dx.doi.org/10.1016/S0764-4469(01)01350-6
15.Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med. 2007;13:688-94. http://dx.doi.org/10.1038/nm1577 PMid:17486089
16.Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 2010;44:971-82. http://dx.doi.org/10.3109/10715762.2010.500328 PMid:20815764
17.Ohta S. Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications. Curr Pharm Des. 2011;17:2241-52
http://dx.doi.org/10.2174/138161211797052664 PMid:21736547 PMCid:3257754
18.Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S, et al. Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem Biophys Res Commun. 2008;375:346-50. http://dx.doi.org/10.1016/j.bbrc.2008.08.020 PMid:18706888
19.Fu Y, Ito M, Fujita Y, Ichihara M, Masuda A, Suzuki Y, et al. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson’s disease. Neurosci Lett. 2009;453:81-5.
http://dx.doi.org/10.1016/j.neulet.2009.02.016 PMid:19356598
20.Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun. 2008;377:1195-8. http://dx.doi.org/10.1016/j.bbrc.2008.10.156 PMid:18996093
21.Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009;64:753-61. http://dx.doi.org/10.1007/s00280-008-0924-2 PMid:19148645
22.Cardinal JS, Zhan J, Wang Y, Sugimoto R, Tsung A, McCurry KR, et al. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int. 2010;77:101-9. http://dx.doi.org/10.1038/ki.2009.421 PMid:19907413
23.Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, Nakamura N, et al. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res. 2008;28:137-43. http://dx.doi.org/10.1016/j.nutres.2008.01.008 PMid:19083400
24.Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr. 2010;46:140-9. http://dx.doi.org/10.3164/jcbn.09-100 PMid:20216947 PMCid:2831093
25.Nakayama M, Nakano H, Hamada H, Itami N, Nakazawa R, Ito S. A novel bioactive haemodia-lysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial. Nephrol Dial Transplant. 2010;25:3026-33.
http://dx.doi.org/10.1093/ndt/gfq196 PMid:20388631
26.Ono H, Nishijima Y, Adachi N, Tachibana S, Chitoku S, Mukaihara S, et al. Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study. Med Gas Res. 2011;1:12. http://dx.doi.org/10.1186/2045-9912-1-12 PMid:22146068 PMCid:3231971
27.Ito M, Ibi T, Sahashi K, Ichihara M, Ito M, Ohno K. Open-label trial and randomized, double-blind, placebo-controlled, crossover trial of hydrogen-enriched water for mitochondrial and inflammatory myopathies. Med Gas Res. 2011;1:24. http://dx.doi.org/10.1186/2045-9912-1-24 PMid:22146674 PMCid:3231939
28.Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297:842-57. http://dx.doi.org/10.1001/jama.297.8.842 PMid:17327526
29.James AM, Cocheme HM, Murphy MP. Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mech Ageing Dev. 2005;126:982-6.
http://dx.doi.org/10.1016/j.mad.2005.03.026 PMid:15923020
30.Abraini JH, Gardette-Chauffour MC, Martinez E, Rostain JC, Lemaire C. Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture. J Appl Physiol. 1994;76:1113-8.
PMid:8005852
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-10-4 11:43
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社